Natixis’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,500
| Closed | -$49.4K | – | 953 |
|
|
2024
Q4 | $49.4K | Buy |
+5,500
| New | +$49.4K | ﹤0.01% | 869 |
|
|
2024
Q2 | – | Sell |
-50,717
| Closed | -$254K | – | 986 |
|
|
2024
Q1 | $254K | Sell |
50,717
-27,897
| -35% | -$140K | ﹤0.01% | 675 |
|
|
2023
Q4 | $707K | Sell |
78,614
-217,541
| -73% | -$1.96M | 0.01% | 558 |
|
|
2023
Q3 | $2.3M | Buy |
296,155
+33,899
| +13% | +$263K | 0.02% | 377 |
|
|
2023
Q2 | $2.54M | Sell |
262,256
-963,231
| -79% | -$9.32M | 0.02% | 377 |
|
|
2023
Q1 | $13.4M | Buy |
1,225,487
+250,544
| +26% | +$2.75M | 0.12% | 147 |
|
|
2022
Q4 | $4.21M | Buy |
974,943
+846,998
| +662% | +$3.66M | 0.02% | 370 |
|
|
2022
Q3 | $977K | Sell |
127,945
-872,055
| -87% | -$6.66M | ﹤0.01% | 728 |
|
|
2022
Q2 | $9.91M | Hold |
1,000,000
| – | – | 0.04% | 283 |
|
|
2022
Q1 | $12.4M | Buy |
1,000,000
+500,000
| +100% | +$6.19M | 0.04% | 367 |
|
|
2021
Q4 | $11.4M | Buy |
+500,000
| New | +$11.4M | 0.04% | 355 |
|